U.S. stock futures rose on Monday after Friday’s sharp fall as investors digested the tariff updates and earnings reports.

European shares edged up on Monday but news of US president Donald Trump’s plan to tariff steel and aluminium hit some stocks ...

Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...

Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $4.02 per share, down from $4.20 per share in the year-ago period. Vertex Pharmaceuticals projects quarterly ...

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will ...

Four different Kentucky lobbyists made more than $1 million for their efforts to influence policy and government over the ...

Biotechnology Market OverviewThe Biotechnology Market report delivers crucial insights into the market's growth trajectory ...

The U.S. hedge fund, which manages around $70 billion in assets, is one of Wall Street's most influential investors, known for pressuring companies to fire management, break apart and spin off ...

Sticky inflation provides the Fed with little impetus to cut interest rates - a trend highlighted by the central bank in January, when it kept interest rates unchanged. Analysts and Federal Reserve ...

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name ...